- Home
- GCTS vs ATRA Comparison
GCTS vs ATRA Comparison
Compare GCTS & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTS
- ATRA
- Stock Information
- Founded
- GCTS 1998
- ATRA 2012
- Country
- GCTS United States
- ATRA United States
- Employees
- GCTS N/A
- ATRA N/A
- Industry
- GCTS Blank Checks
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GCTS Finance
- ATRA Health Care
- Exchange
- GCTS Nasdaq
- ATRA Nasdaq
- Market Cap
- GCTS 82.1M
- ATRA 97.0M
- IPO Year
- GCTS N/A
- ATRA 2014
- Fundamental
- Price
- GCTS $1.46
- ATRA $14.81
- Analyst Decision
- GCTS Strong Buy
- ATRA Strong Buy
- Analyst Count
- GCTS 1
- ATRA 3
- Target Price
- GCTS $5.00
- ATRA $21.00
- AVG Volume (30 Days)
- GCTS 256.2K
- ATRA 63.7K
- Earning Date
- GCTS 11-13-2025
- ATRA 11-11-2025
- Dividend Yield
- GCTS N/A
- ATRA N/A
- EPS Growth
- GCTS N/A
- ATRA N/A
- EPS
- GCTS N/A
- ATRA 0.56
- Revenue
- GCTS $6,073,000.00
- ATRA $188,667,000.00
- Revenue This Year
- GCTS N/A
- ATRA N/A
- Revenue Next Year
- GCTS $1,597.96
- ATRA N/A
- P/E Ratio
- GCTS N/A
- ATRA $26.29
- Revenue Growth
- GCTS N/A
- ATRA 202.41
- 52 Week Low
- GCTS $0.90
- ATRA $5.01
- 52 Week High
- GCTS $2.86
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- GCTS 47.61
- ATRA 56.60
- Support Level
- GCTS $1.42
- ATRA $14.01
- Resistance Level
- GCTS $1.55
- ATRA $16.28
- Average True Range (ATR)
- GCTS 0.08
- ATRA 1.08
- MACD
- GCTS -0.01
- ATRA -0.05
- Stochastic Oscillator
- GCTS 35.00
- ATRA 46.11
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).